ORVILLE JACOB A (CIK 1263312) reported 33 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-25). Recent activity: Buy ABT (13,255 shares), Buy EXAS (53,323 shares), Sell EXAS (153,726 shares), Sell EXAS (1,774 shares), Buy EXAS (16,051 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-25 | ABBOTT LABORATORIES (ABT) | Senior Vice President | Buy | 13,255 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 53,323 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 153,726 | $0 |
| 2026-03-23 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 1,774 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 16,051 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 1,859 | $189,283 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 9,450 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 4,442 | $452,284 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 14,845 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 6,978 | $710,500 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 28,779 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 13,527 | $1.4M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 3,955 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 7,544 | $768,130 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 42,523 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 19,986 | $2.0M |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 20,584 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 9,675 | $985,108 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 9,416 | $0 |
| 2025-12-30 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 4,426 | $450,655 |
| 2025-11-21 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 5,000 | $375,000 |
| 2025-08-07 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 5,350 | $0 |
| 2025-08-07 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 2,515 | $117,777 |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Buy | 4,725 | $0 |
| 2025-03-04 | EXACT SCIENCES CORP (EXAS) | EVP, GM, Screening | Sell | 2,221 | $106,208 |
Source: SEC Form 4 filings · as of 2026-03-25